Login / Signup
Shaymaa M M Yahya
Scopus Author ID
ORCID
Publication Activity (10 Years)
Years Active: 2019-2023
Publications (10 Years): 7
Top Topics
Poor Prognosis
Genome Wide
Signaling Pathway
Oxidative Stress
Top Venues
Scientific reports
Molecular biology reports
Naunyn-Schmiedeberg's archives of pharmacology
Breast cancer research and treatment
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Heba K Nabih
,
Ahmad R Hamed
,
Shaymaa M M Yahya
Anti-proliferative effect of melatonin in human hepatoma HepG2 cells occurs mainly through cell cycle arrest and inflammation inhibition.
Scientific reports
13 (1) (2023)
Heba K Nabih
,
Ahmad R Hamed
,
Shaymaa M M Yahya
Anti-proliferative effect of melatonin in human hepatoma HepG2 cells occurs mainly through cell cycle arrest and inflammation inhibition.
Scientific reports
13 (1) (2023)
Ahmad R Hamed
,
Shaymaa M M Yahya
,
Heba K Nabih
Anti-drug resistance, anti-inflammation, and anti-proliferation activities mediated by melatonin in doxorubicin-resistant hepatocellular carcinoma: in vitro investigations.
Naunyn-Schmiedeberg's archives of pharmacology
(2023)
Heba K Nabih
,
Ahmad R Hamed
,
Shaymaa M M Yahya
Anti-proliferative effect of melatonin in human hepatoma HepG2 cells occurs mainly through cell cycle arrest and inflammation inhibition.
Scientific reports
13 (1) (2023)
Shaymaa M M Yahya
,
Heba K Nabih
,
Ghada H Elsayed
,
Shimaa Ibrahim Abdelmenym Mohamed
,
Asmaa M Elfiky
,
Sohair M Salem
Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene.
Breast cancer research and treatment
(2023)
Heba K Nabih
,
Ahmad R Hamed
,
Shaymaa M M Yahya
Anti-proliferative effect of melatonin in human hepatoma HepG2 cells occurs mainly through cell cycle arrest and inflammation inhibition.
Scientific reports
13 (1) (2023)
Shaymaa M M Yahya
,
Salma M Abdelnasser
,
Ahmad R Hamed
,
Osama H El Sayed
,
Mohsen S Asker
Newly isolated marine bacterial exopolysaccharides enhance antitumor activity in HepG2 cells via affecting key apoptotic factors and activating toll like receptors.
Molecular biology reports
46 (6) (2019)